Stockreport

Chemomab Awarded New European Patent for CM-101, Its First-in Class Monoclonal Antibody in Phase 2 Clinical Development for Primary Sclerosing Cholangitis [Yahoo! Finance]

Chemomab Therapeutics Ltd. - American Depositary Shares  (CMMB) 
PDF —Further Extends Protections Afforded by CM-101 Composition of Matter and Methods and Use Patents That Have Issued in the U.S., Europe, Israel and Related Territories— [Read more]